Citations (96)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Bashir Lawal, Yu-Cheng Kuo, Maryam Rachmawati Sumitra, Alexander T H Wu & Hsu-Shan Huang. (2021) In vivo Pharmacokinetic and Anticancer Studies of HH-N25, a Selective Inhibitor of Topoisomerase I, and Hormonal Signaling for Treating Breast Cancer. Journal of Inflammation Research 14, pages 4901-4913.
Read now
Read now
Subramanya Srikantan, Kotb Abdelmohsen, Eun Kyung Lee, Kumiko Tominaga, Sarah S. Subaran, Yuki Kuwano, Ritu Kulshrestha, Rohit Panchakshari, Hyeon Ho Kim, Xiaoling Yang, Jennifer L. Martindale, Bernard S. Marasa, Mihee M. Kim, Robert P. Wersto, Fred E. Indig, Dipanjan Chowdhury & Myriam Gorospe. (2011) Translational Control of TOP2A Influences Doxorubicin Efficacy. Molecular and Cellular Biology 31:18, pages 3790-3801.
Read now
Read now
George Pentheroudakis, Anna Goussia, Evangelos Voulgaris, Konstantinos Nikolaidis, Evaggelia Ioannidou, Alexandra Papoudou-Bai, Konstantina Grepi, Panagiotis Kanavaros, Nicholas Pavlidis & Maria Bai. (2010) High levels of topoisomerase IIα protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment. Leukemia & Lymphoma 51:7, pages 1260-1268.
Read now
Read now
Articles from other publishers (93)
Manar G. Salem, Sara A. Abu El-ata, Elsherbiny H. Elsayed, Suraj N. Mali, Hussah Abdullah Alshwyeh, Ghassan Almaimani, Riyad A. Almaimani, Hussain A. Almasmoum, Najla Altwaijry, Ebtesam Al-Olayan, Essa M. Saied & Mohamed F. Youssef. (2023) Novel 2-substituted-quinoxaline analogs with potential antiproliferative activity against breast cancer: insights into cell cycle arrest, topoisomerase II, and EGFR activity. RSC Advances 13:47, pages 33080-33095.
Crossref
Crossref
Federica Battistin, Célia Fernandes, Paula. D. Raposinho, Olivier Blacque, António Paulo & Roger Alberto. (2023)
In vivo
and
in vitro
studies of [M(η
6
-pseudoerlotinib)
2
]
+
sandwich complexes (M = Re,
99m
Tc)
. Dalton Transactions 52:43, pages 15757-15766.
Crossref
Crossref
Jessica Ceramella, Rubina Troiano, Domenico Iacopetta, Annaluisa Mariconda, Michele Pellegrino, Alessia Catalano, Carmela Saturnino, Stefano Aquaro, Maria Stefania Sinicropi & Pasquale Longo. (2023) Synthesis of Novel N-Heterocyclic Carbene-Ruthenium (II) Complexes, “Precious” Tools with Antibacterial, Anticancer and Antioxidant Properties. Antibiotics 12:4, pages 693.
Crossref
Crossref
Lina Ammar, Hung-Yu Lin, Shou-Ping Shih, Tsen-Ni Tsai, Yu-Ting Syu, Mohammad Abdel-Halim, Tsong-Long Hwang & Ashraf H. Abadi. (2023) Novel 9-Benzylaminoacridine Derivatives as Dual Inhibitors of Phosphodiesterase 5 and Topoisomerase II for the Treatment of Colon Cancer. Molecules 28:2, pages 840.
Crossref
Crossref
Vishal Singh, Tayyaba Afshan, Pankaj Tyagi, Pritish Kumar Varadwaj & Amaresh Kumar Sahoo. (2023) Recent development of multi-targeted inhibitors of human topoisomerase II enzyme as potent cancer therapeutics. International Journal of Biological Macromolecules 226, pages 473-484.
Crossref
Crossref
Leandro Cerchietti. 2023. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
637
649
.
Huong Le-Petross, R. Jason Stafford, Isabelle Bedrosian, Patrick B. Garvey, Wendy A. Woodward & Stacy L. Moulder-Thompson. 2023. Oncologic Imaging : a Multidisciplinary Approach. Oncologic Imaging : a Multidisciplinary Approach
476
502
.
Rajkumar Nagavath, Satheesh Kumar Nukala, Ravikumar Reddy Sagam, Narsimha Sirassu, Veeranna Guguloth, Pavan Kamarajugadda, Suresh Paidakula & Narasimha Swamy Thirukovela. (2022)
Anticancer Evaluation of Some New 4
β
‐Imidazolopodophyllotoxin ‐Aromatic Amides
. ChemistrySelect 7:39.
Crossref
Crossref
Maria K. Lagou, Dimitra P. Anastasiadou & George S. Karagiannis. (2022) A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy. Frontiers in Immunology 13.
Crossref
Crossref
Iqubal Singh, Vijay Luxami, Diptiman Choudhury & Kamaldeep Paul. (2022) Synthesis and photobiological applications of naphthalimide–benzothiazole conjugates: cytotoxicity and topoisomerase IIα inhibition. RSC Advances 12:1, pages 483-497.
Crossref
Crossref
John L. Nitiss, Kostantin Kiianitsa, Yilun Sun, Karin C. Nitiss & Nancy Maizels. (2021) Topoisomerase Assays. Current Protocols 1:10.
Crossref
Crossref
Madeleine Bossaert, Angélique Pipier, Jean-Francois Riou, Céline Noirot, Linh-Trang Nguyên, Remy-Felix Serre, Olivier Bouchez, Eric Defrancq, Patrick Calsou, Sébastien Britton & Dennis Gomez. (2021) Transcription-associated topoisomerase 2α (TOP2A) activity is a major effector of cytotoxicity induced by G-quadruplex ligands. eLife 10.
Crossref
Crossref
Maria Kozurkova, Danica Sabolova & Pavol Kristian. (2020) A new look at 9‐substituted acridines with various biological activities. Journal of Applied Toxicology 41:1, pages 175-189.
Crossref
Crossref
Silvia Paukovcekova, Jan Skoda, Jakub Neradil, Erika Mikulenkova, Petr Chlapek, Jaroslav Sterba, Des R. Richardson & Renata Veselska. (2020) Novel Thiosemicarbazones Sensitize Pediatric Solid Tumor Cell-Types to Conventional Chemotherapeutics through Multiple Molecular Mechanisms. Cancers 12:12, pages 3781.
Crossref
Crossref
Jude I. Ayogu & Amaechi S. Odoh. (2020) Prospects and Therapeutic Applications of Cardiac Glycosides in Cancer Remediation. ACS Combinatorial Science 22:11, pages 543-553.
Crossref
Crossref
Jose M. Arencibia, Nicoletta Brindani, Sebastian Franco-Ulloa, Michela Nigro, Jissy Akkarapattiakal Kuriappan, Giuliana Ottonello, Sine Mandrup Bertozzi, Maria Summa, Stefania Girotto, Rosalia Bertorelli, Andrea Armirotti & Marco De Vivo. (2020)
Design, Synthesis, Dynamic Docking, Biochemical Characterization, and
in Vivo
Pharmacokinetics Studies of Novel Topoisomerase II Poisons with Promising Antiproliferative Activity
. Journal of Medicinal Chemistry 63:7, pages 3508-3521.
Crossref
Crossref
Žiga Skok, Nace Zidar, Danijel Kikelj & Janez Ilaš. (2019) Dual Inhibitors of Human DNA Topoisomerase II and Other Cancer-Related Targets. Journal of Medicinal Chemistry 63:3, pages 884-904.
Crossref
Crossref
Karin C. Nitiss, John L. Nitiss & Leslyn A. Hanakahi. (2019) DNA Damage by an essential enzyme: A delicate balance act on the tightrope. DNA Repair 82, pages 102639.
Crossref
Crossref
Sivakumar Vijayaraghavalu & Vinod Labhasetwar. (2018) Nanogel-mediated delivery of a cocktail of epigenetic drugs plus doxorubicin overcomes drug resistance in breast cancer cells. Drug Delivery and Translational Research 8:5, pages 1289-1299.
Crossref
Crossref
Amol Mehta, Chidiebere U. Awah & Adam M. Sonabend. (2018) Topoisomerase II Poisons for Glioblastoma; Existing Challenges and Opportunities to Personalize Therapy. Frontiers in Neurology 9.
Crossref
Crossref
José Miguel P. Ferreira de Oliveira, Ana Rita Pacheco, Laura Coutinho, Helena Oliveira, Sónia Pinho, Luis Almeida, Eduarda Fernandes & Conceição Santos. (2017) Combination of etoposide and fisetin results in anti-cancer efficiency against osteosarcoma cell models. Archives of Toxicology 92:3, pages 1205-1214.
Crossref
Crossref
V. Ganga Reddy, Srinivasa Reddy Bonam, T. Srinivasa Reddy, Ravikumar Akunuri, V.G.M. Naidu, V. Lakshma Nayak, Suresh K. Bhargava, H.M. Sampath Kumar, P. Srihari & Ahmed Kamal. (2018) 4 β -amidotriazole linked podophyllotoxin congeners: DNA topoisomerase-IIα inhibition and potential anticancer agents for prostate cancer. European Journal of Medicinal Chemistry 144, pages 595-611.
Crossref
Crossref
Jay Anand, Yilun Sun, Yang Zhao, Karin C. Nitiss & John L. Nitiss. 2018. DNA Topoisomerases. DNA Topoisomerases
283
299
.
Djihad Bencherit, Sylvie Remy, Yves Le Vern, Tereza Vychodil, Luca D. Bertzbach, Benedikt B. Kaufer, Caroline Denesvre & Laëtitia Trapp-Fragnet. (2017) Induction of DNA Damages upon Marek's Disease Virus Infection: Implication in Viral Replication and Pathogenesis. Journal of Virology 91:24.
Crossref
Crossref
Temilolu Idowu & Frank Schweizer. (2017) Ubiquitous Nature of Fluoroquinolones: The Oscillation between Antibacterial and Anticancer Activities. Antibiotics 6:4, pages 26.
Crossref
Crossref
Mei Hong, Ming-Qiang Ren, Jeane Silva, Ananya Paul, W. David Wilson, Carsten Schroeder, Paul Weinberger, John Janik & Zhonglin Hao. (2017) YM155 inhibits topoisomerase function. Anti-Cancer Drugs 28:2, pages 142-152.
Crossref
Crossref
Ashutosh Kumar, Marilyn Ehrenshaft, Erik J. Tokar, Ronald P. Mason & Birandra K. Sinha. (2016) Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells. Biochimica et Biophysica Acta (BBA) - General Subjects 1860:7, pages 1519-1527.
Crossref
Crossref
Zhensheng Liu, Hongliang Liu, Fengqin Gao, Kristina R. Dahlstrom, Erich M. Sturgis & Qingyi Wei. (2016) Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck—A case-control study. DNA Repair 40, pages 18-26.
Crossref
Crossref
Md. Abu Saleh, Md. Solayman, Mohammad Mazharol Hoque, Mohammad A. K. Khan, Mohammed G. Sarwar & Mohammad A. Halim. (2016)
Inhibition of DNA Topoisomerase Type II
α
(TOP2A) by Mitoxantrone and Its Halogenated Derivatives: A Combined Density Functional and Molecular Docking Study
. BioMed Research International 2016, pages 1-12.
Crossref
Crossref
Robert Göstl & Stefan Hecht. (2015) Photoreversible Prodrugs and Protags: Switching the Release of Maleimides by Using Light under Physiological Conditions. Chemistry – A European Journal 21:11, pages 4422-4427.
Crossref
Crossref
Benet Pera & Leandro Cerchietti. 2015. Epigenetic Cancer Therapy. Epigenetic Cancer Therapy
667
676
.
Kashmiri Lal, C. P. Kaushik, Krishan Kumar, Ashwani Kumar, Asif Khurshid Qazi, Abid Hamid & Sundeep Jaglan. (2014) One-pot synthesis and cytotoxic evaluation of amide-linked 1,4-disubstituted 1,2,3-bistriazoles. Medicinal Chemistry Research 23:11, pages 4761-4770.
Crossref
Crossref
Zhi-Yuan Gong, Hiroyasu Kidoya, Tomomi Mohri, Yinglu Han & Nobuyuki Takakura. (2014) DNA Damage Enhanced by the Attenuation of SLD5 Delays Cell Cycle Restoration in Normal Cells but Not in Cancer Cells. PLoS ONE 9:10, pages e110483.
Crossref
Crossref
Pierre Daumar, Brian M. Zeglis, Nicholas Ramos, Vadim Divilov, Kuntal Kumar Sevak, NagaVaraKishore Pillarsetty & Jason S. Lewis. (2014) Synthesis and evaluation of 18F-labeled ATP competitive inhibitors of topoisomerase II as probes for imaging topoisomerase II expression. European Journal of Medicinal Chemistry 86, pages 769-781.
Crossref
Crossref
A. M. Sonabend, A. S. Carminucci, B. Amendolara, M. Bansal, R. Leung, L. Lei, R. Realubit, H. Li, C. Karan, J. Yun, C. Showers, R. Rothcock, J. O, A. Califano, P. Canoll & J. N. Bruce. (2014) Convection-enhanced delivery of etoposide is effective against murine proneural glioblastoma. Neuro-Oncology 16:9, pages 1210-1219.
Crossref
Crossref
Etchison Ryan, A. Jacobson Blake, A. Benoit, M. Ferguson David & A. Kratzke Robert. (2012) Efficacy of substituted 9-aminoacridine derivatives in small cell lung cancer. Investigational New Drugs 31:2, pages 285-292.
Crossref
Crossref
Sivakumar Vijayaraghavalu, Josephine Kamtai Dermawan, Venugopalan Cheriyath & Vinod Labhasetwar. (2012)
Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of
p21
Gene Expression Leading to G2/M Cycle Arrest
. Molecular Pharmaceutics 10:1, pages 337-352.
Crossref
Crossref
Yuan Lin, Dapeng Chen, Li Wang & Dongmei Ye. 2013. Natural Products. Natural Products
3743
3755
.
Kyoung Hwangbo, Ming Shan Zheng, Young-Jin Kim, Jong-Yeop Im, Chong-Soon Lee, Mi-Hee Woo, Yurngdong Jahng, Hyun-Wook Chang & Jong-Keun Son. (2012) Inhibition of DNA topoisomerases I and II of compounds from Reynoutria japonica. Archives of Pharmacal Research 35:9, pages 1583-1589.
Crossref
Crossref
Ahmad Raza, Blake A. Jacobson, Adam Benoit, Manish R. Patel, Joe Jay-Dixon, Hiroshi Hiasa, David M. Ferguson & Robert Arthur Kratzke. (2011) Novel acridine-based agents with topoisomerase II inhibitor activity suppress mesothelioma cell proliferation and induce apoptosis. Investigational New Drugs 30:4, pages 1443-1448.
Crossref
Crossref
John L. Nitiss, Eroica Soans, Anna Rogojina, Aman Seth & Margarita Mishina. (2012) Topoisomerase Assays. Current Protocols in Pharmacology 57:1.
Crossref
Crossref
S. M. Attia. (2011) Molecular cytogenetic evaluation of the aneugenic effects of teniposide in somatic and germinal cells of male mice. Mutagenesis 27:1, pages 31-39.
Crossref
Crossref
Huong Le-Petross, R. Jason Stafford, Isabelle Bedrosian, Patrick B. Garvey, Wendy A. Woodward & Stacy L. Moulder-Thompson. 2012. Oncologic Imaging: A Multidisciplinary Approach. Oncologic Imaging: A Multidisciplinary Approach
479
507
.
John L. Nitiss, Eroica Soans, Jeffrey Berk, Aman Seth, Margarita Mishina & Karin C. Nitiss. 2012. DNA Topoisomerases and Cancer. DNA Topoisomerases and Cancer
381
407
.
Lin Du, Hong-Chun Liu, Wei Fu, De-Hai Li, Qiu-Ming Pan, Tian-Jiao Zhu, Mei-Yu Geng & Qian-Qun Gu. (2011) Unprecedented Citrinin Trimer Tricitinol B Functions as a Novel Topoisomerase IIα Inhibitor. Journal of Medicinal Chemistry 54:16, pages 5796-5810.
Crossref
Crossref
S. A. Bakheet, S. M. Attia, N. M. AL-Rasheed, M. M. Al-harbi, A. E. Ashour, H. M. Korashy, A. R. Abd-Allah, Q. Saquib, A. A. Al-Khedhairy & J. Musarrat. (2011) Salubrious effects of dexrazoxane against teniposide-induced DNA damage and programmed cell death in murine marrow cells. Mutagenesis 26:4, pages 533-543.
Crossref
Crossref
Sarah L. Elliott, Clark Crawford, Evan Mulligan, Geoffrey Summerfield, Paula Newton, Jonathan Wallis, Tryfonia Mainou-Fowler, Paul Evans, Clare Bedwell, Barbara W. Durkacz & Elaine Willmore. (2011) Mitoxantrone in combination with an inhibitor of DNA-dependent protein kinase: a potential therapy for high risk B-cell chronic lymphocytic leukaemia. British Journal of Haematology 152:1, pages 61-71.
Crossref
Crossref
Ping Wang, Chung‐Hang Leung, Dik‐Lung Ma, Wei Lu & Chi‐Ming Che. (2010) Organoplatinum(II) Complexes with Nucleobase Motifs as Inhibitors of Human Topoisomerase II Catalytic Activity. Chemistry – An Asian Journal 5:10, pages 2271-2280.
Crossref
Crossref
Zhi Wei Quan, Yong Yang, Ji Yu Li, Wei Gong, Yi Yu Qin & Song Gang Li. (2010) The mechanisms of somatostatin induced enhanced chemosensitivity of gallbladder cancer cell line to doxorubicin: Cell cycle modulation plus target enzyme up-regulation. Biomedicine & Pharmacotherapy 64:7, pages 451-457.
Crossref
Crossref
Farzaneh Foroughinia, Katayoun Javidnia, Zahra Amirghofran, Ahmadreza Mehdipour & Ramin Miri. (2008) Design and synthesis of new symmetrical derivatives of dihydropyridine containing a pyridyl group on the 3, 5-positions and evaluation of their cytotoxic and multidrug resistance reversal activity. Journal of Pharmacy and Pharmacology 60:11, pages 1481-1489.
Crossref
Crossref
Ilona Schonn, Jana Hennesen & Dorothee C. Dartsch. (2009) Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage. Apoptosis 15:2, pages 162-172.
Crossref
Crossref
Chunqi Hu, Danqing Xu, Wenting Du, Shijing Qian, Li Wang, Jianshu Lou, Qiaojun He, Bo Yang & Yongzhou Hu. (2010) Novel 4β-anilino-podophyllotoxin derivatives: design synthesis and biological evaluation as potent DNA-topoisomerase II poisons and anti-MDR agents. Mol. BioSyst. 6:2, pages 410-420.
Crossref
Crossref
Xin Zhang, Feng Mu, Bobby Robinson & Pengfei Wang. (2010) Concise route to the key intermediate for divergent synthesis of C7-substituted fluoroquinolone derivatives. Tetrahedron Letters 51:4, pages 600-601.
Crossref
Crossref
Marina Gálvez-Peralta, Jennifer S. Hackbarth, Karen S. Flatten, Scott H. Kaufmann, Hiroshi Hiasa, Chenguo Xing & David M. Ferguson. (2009) On the role of topoisomerase I in mediating the cytotoxicity of 9-aminoacridine-based anticancer agents. Bioorganic & Medicinal Chemistry Letters 19:15, pages 4459-4462.
Crossref
Crossref
John L. Nitiss. (2009) Targeting DNA topoisomerase II in cancer chemotherapy. Nature Reviews Cancer 9:5, pages 338-350.
Crossref
Crossref
Iha Park, Kwang-Kyun Park, Jung Han Yoon Park & Won-Yoon Chung. (2009) Isoliquiritigenin induces G2 and M phase arrest by inducing DNA damage and by inhibiting the metaphase/anaphase transition. Cancer Letters 277:2, pages 174-181.
Crossref
Crossref
Melanie Esselen, Jessica Fritz, Melanie Hutter & Doris Marko. (2009) Delphinidin Modulates the DNA-Damaging Properties of Topoisomerase II Poisons. Chemical Research in Toxicology 22:3, pages 554-564.
Crossref
Crossref
J. E. Deweese & N. Osheroff. (2008) The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing. Nucleic Acids Research 37:3, pages 738-748.
Crossref
Crossref
Lisa M. Oppegard, Andrei V. Ougolkov, Doris N. Luchini, Renee A. Schoon, John R. Goodell, Harneet Kaur, Daniel D. Billadeau, David M. Ferguson & Hiroshi Hiasa. (2009) Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase II. European Journal of Pharmacology 602:2-3, pages 223-229.
Crossref
Crossref
Omari J. Bandele & Neil Osheroff. 2009. DNA Topoisomerases. DNA Topoisomerases
39
47
.
Omari J. Bandele & Neil Osheroff. (2008) The Efficacy of Topoisomerase II-Targeted Anticancer Agents Reflects the Persistence of Drug-Induced Cleavage Complexes in Cells. Biochemistry 47:45, pages 11900-11908.
Crossref
Crossref
Anna T. Rogojina & John L. Nitiss. (2008) Isolation and Characterization of mAMSA-hypersensitive Mutants. Journal of Biological Chemistry 283:43, pages 29239-29250.
Crossref
Crossref
Omari J. Bandele, Sara J. Clawson & Neil Osheroff. (2008) Dietary Polyphenols as Topoisomerase II Poisons: B Ring and C Ring Substituents Determine the Mechanism of Enzyme-Mediated DNA Cleavage Enhancement. Chemical Research in Toxicology 21:6, pages 1253-1260.
Crossref
Crossref
Omari J. Bandele & Neil Osheroff. (2008) (–)-Epigallocatechin Gallate, A Major Constituent of Green Tea, Poisons Human Type II Topoisomerases. Chemical Research in Toxicology 21:4, pages 936-943.
Crossref
Crossref
Lauren M. Congdon, Alan Pourpak, Aluvia M. Escalante, Robert T. Dorr & Terry H. Landowski. (2008) Proteasomal inhibition stabilizes topoisomerase IIα protein and reverses resistance to the topoisomerase II poison ethonafide (AMP-53, 6-ethoxyazonafide). Biochemical Pharmacology 75:4, pages 883-890.
Crossref
Crossref
S Moulder & GN Hortobagyi. (2007) Advances in the Treatment of Breast Cancer. Clinical Pharmacology & Therapeutics 83:1, pages 26-36.
Crossref
Crossref
John R. Goodell, Andrei V. Ougolkov, Hiroshi Hiasa, Harneet Kaur, Rory Remmel, Daniel D. Billadeau & David M. Ferguson. (2007) Acridine-Based Agents with Topoisomerase II Activity Inhibit Pancreatic Cancer Cell Proliferation and Induce Apoptosis. Journal of Medicinal Chemistry 51:2, pages 179-182.
Crossref
Crossref
Dave Li, Joseph Hackett, Maria Chan, Gene Pennello & Steve Gutman. 2008. Cancer Proteomics. Cancer Proteomics
237
258
.
Cheng-Ying Xie, Hong Zhu, Li-Ping Lin, Ze-Hong Miao, Mei-Yu Geng, Yu-Jun Cai, Yi Chen, Hua-Jun Zhao, Hai-Bin Luo, Xiong-Wen Zhang, Li-Ming Fan, Yue-Mao Shen & Jian Ding. (2007) MFTZ-1, an actinomycetes subspecies–derived antitumor macrolide, functions as a novel topoisomerase II poison. Molecular Cancer Therapeutics 6:11, pages 3059-3070.
Crossref
Crossref
A. Kathleen McClendon & Neil Osheroff. (2007) DNA topoisomerase II, genotoxicity, and cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 623:1-2, pages 83-97.
Crossref
Crossref
Alan Pourpak, Terry H. Landowski & Robert T. Dorr. (2007) Ethonafide-Induced Cytotoxicity Is Mediated by Topoisomerase II Inhibition in Prostate Cancer Cells. Journal of Pharmacology and Experimental Therapeutics 321:3, pages 1109-1117.
Crossref
Crossref
Bart A. Jessen, Leo Lee, Tatiana Koudriakova, Morgan Haines, Karen Lundgren, Sharon Price, Jim Nonomiya, Cristina Lewis & Gregory J. Stevens. (2007) Peripheral white blood cell toxicity induced by broad spectrum cyclin‐dependent kinase inhibitors. Journal of Applied Toxicology 27:2, pages 133-142.
Crossref
Crossref
Mobeen Malik, Karin C. Nitiss, Vanessa Enriquez-Rios & John L. Nitiss. (2006) Roles of nonhomologous end-joining pathways in surviving topoisomerase II–mediated DNA damage. Molecular Cancer Therapeutics 5:6, pages 1405-1414.
Crossref
Crossref
Suk-June Choi, Hyen Joo Park, Sang Kook Lee, Sang Woong Kim, Gyoonhee Han & Hea-Young Park Choo. (2006) Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity. Bioorganic & Medicinal Chemistry 14:4, pages 1229-1235.
Crossref
Crossref
Krzysztof Bielawski, Katarzyna Winnicka & Anna Bielawska. (2006) Inhibition of DNA Topoisomerases I and II, and Growth Inhibition of Breast Cancer MCF-7 Cells by Ouabain, Digoxin and Proscillaridin A. Biological & Pharmaceutical Bulletin 29:7, pages 1493-1497.
Crossref
Crossref
P. Schmid, K. Possinger & H. D. Peters. 2006. Kompendium Internistische Onkologie. Kompendium Internistische Onkologie
1455
1537
.
Miranda D. Gray, Melissa Mann, John L. Nitiss & Linda M. Hendershot. (2005) Activation of the Unfolded Protein Response Is Necessary and Sufficient for Reducing Topoisomerase IIα Protein Levels and Decreasing Sensitivity to Topoisomerase-Targeted Drugs. Molecular Pharmacology 68:6, pages 1699-1707.
Crossref
Crossref
Matthew J. Neale, Jing Pan & Scott Keeney. (2005) Endonucleolytic processing of covalent protein-linked DNA double-strand breaks. Nature 436:7053, pages 1053-1057.
Crossref
Crossref
Yeu-Chin Chen, Jung-Mao Chou, Louis Letendre & Chin-Yang Li. (2005) Clinical importance of bone marrow monocytic nodules in patients with myelodysplasia: Retrospective analysis of 21 cases. American Journal of Hematology 79:4, pages 329-331.
Crossref
Crossref
Michael Jahnz, Miguel Ángel Medina & Petra Schwille. (2005) A Novel Homogenous Assay for Topoisomerase II Action and Inhibition. ChemBioChem 6:5, pages 920-926.
Crossref
Crossref
R. Hunter Lindsey, Ryan P. Bender & Neil Osheroff. (2005) Stimulation of topoisomerase II-mediated DNA cleavage by benzene metabolites. Chemico-Biological Interactions 153-154, pages 197-205.
Crossref
Crossref
Andrew T. Vaughan, Christopher J. Betti, Michael J. Villalobos, Kumpati Premkumar, Edith Cline, Qun Jiang & Manuel O. Diaz. (2005) Surviving apoptosis: A possible mechanism of benzene-induced leukemia. Chemico-Biological Interactions 153-154, pages 179-185.
Crossref
Crossref
Jerrylaine Vaughn, Shengli Huang, Irene Wessel, Tina K. Sorensen, Tao Hsieh, Lars H. Jensen, Peter B. Jensen, Maxwell Sehested & John L. Nitiss. (2005) Stability of the Topoisomerase II Closed Clamp Conformation May Influence DNA-stimulated ATP Hydrolysis. Journal of Biological Chemistry 280:12, pages 11920-11929.
Crossref
Crossref
Victor Khor, Charles Yowell, John B. Dame & Thomas C. Rowe. (2005) Expression and characterization of the ATP-binding domain of a malarial Plasmodium vivax gene homologous to the B-subunit of the bacterial topoisomerase DNA gyrase. Molecular and Biochemical Parasitology 140:1, pages 107-117.
Crossref
Crossref
Hans Gelderblom & Alex Sparreboom. 2005. Drugs Affecting Growth of Tumours. Drugs Affecting Growth of Tumours
83
100
.
Elisabeth M. Perchellet, Yang Wang, Rebeka L. Weber, Kaiyan Lou, Duy H. Hua & Jean-Pierre H. Perchellet. (2004) Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling. Anti-Cancer Drugs 15:10, pages 929-946.
Crossref
Crossref
Christine Bal, Brigitte Baldeyrou, Florence Moz, Amélie Lansiaux, Pierre Colson, Laurence Kraus-Berthier, Stéphane Léonce, Alain Pierré, Marie-Françoise Boussard, Anne Rousseau, Michel Wierzbicki & Christian Bailly. (2004) Novel antitumor indenoindole derivatives targeting DNA and topoisomerase II. Biochemical Pharmacology 68:10, pages 1911-1922.
Crossref
Crossref
Jerrylaine V. Walker, Karin C. Nitiss, Lars H. Jensen, Christopher Mayne, Tao Hu, Peter B. Jensen, Maxwell Sehested, Tao Hsieh & John L. Nitiss. (2004) A Mutation in Human Topoisomerase II α Whose Expression Is Lethal in DNA Repair-deficient Yeast Cells. Journal of Biological Chemistry 279:25, pages 25947-25954.
Crossref
Crossref
Mobeen Malik & John L. Nitiss. (2004) DNA Repair Functions That Control Sensitivity to Topoisomerase-Targeting Drugs. Eukaryotic Cell 3:1, pages 82-90.
Crossref
Crossref
Darshan S. Sappal, A. Kathleen McClendon, James A. Fleming, Vala Thoroddsen, Kelly Connolly, Corinne Reimer, Ronald K. Blackman, Christine E. Bulawa, Neil Osheroff, Peter Charlton & Laura A. Rudolph-Owen. (2004) Biological characterization of MLN944: A potent DNA binding agent. Molecular Cancer Therapeutics 3:1, pages 47-58.
Crossref
Crossref
Christian Streffer, H. Bolt, D. Føllesdal, P. Hall, J. G. Hengstler, P. Jakob, D. Oughton, K. Prieß, E. Rehbinder & E. SwatonChristian Streffer, H. Bolt, D. Føllesdal, P. Hall, J. G. Hengstler, P. Jakob, D. Oughton, K. Prieß, E. Rehbinder & E. Swaton. 2004. Low Dose Exposures in the Environment. Low Dose Exposures in the Environment
83
180
.
Buna Wang, Elisabeth M. Perchellet, Yang Wang, Masafumi Tamura, Duy H. Hua & Jean-Pierre H. Perchellet. (2003) Antitumor triptycene bisquinones: a novel synthetic class of dual inhibitors of DNA topoisomerase I and II activities. Anti-Cancer Drugs 14:7, pages 503-514.
Crossref
Crossref
Kenneth D. Bromberg, Alex B. Burgin & Neil Osheroff. (2003) A Two-drug Model for Etoposide Action against Human Topoisomerase IIα. Journal of Biological Chemistry 278:9, pages 7406-7412.
Crossref
Crossref